Aptevo Therapeutics (AP80.F) Q1 2025 Earnings

14FebConfirmed
Q4 2024
Q1 2025
-19.53
-15.48
-11.43
-7.39

Details

Expected EPS
-7.38575
Actual EPS
-8.51982
Surprise EPS
-1.13
Surprise Percent
+15.35%

Description

Aptevo Therapeutics (AP80.F) has reported earnings of -8.51982 per share for Q1 2025.

0 Comments

Share your thoughts